July - Dec 2013
-
BBC Five Live Victoria Derbyshire wins award for MRC Harwell programme
7th November 2013
Our congratulations to Victoria Derbyshire, the BBC Radio Five Live team, and the staff at MRC Harwell for winning the Live journalism - radio category at this years international broadcasting awards.
-
Parkinson drug for multiple sclerosis?
5th November 2013
A drug currently used to treat Parkinson’s disease can repair the nerve damage caused by multiple sclerosis, research using rats and mice has shown.
-
New botox could reduce animal toxicology testing
5th November 2013
Scientists have developed a new form of botox that lasts for months without the toxic side-effects of the current treatment used in the medical and cosmetic industries.
-
The Concordat survey has now closed
4th November 2013
We want your opinion about the draft Concordat and hope you can take the ten minutes it takes to fill in a questionnaire.
-
This House would not ban all forms of animal research
23rd October 2013
The Big Animal Research Debate, an event organised by UAR and IDEA UK, took place in thirty universities last week.
-
The Big Animal Research Debate: Day 4
15th October 2013
The Big Animal Research Debate, an event organised by UAR and IDEA UK, starts today with five debates taking place at Hull University, King’s College London
-
We need to stick with research through the ups and the downs
14th October 2013
You may have noticed the news recently of a ‘breakthrough’ in treating Alzheimer’s disease.
-
‘Turning point’ in Alzheimer’s treatment
10th October 2013
A new compound that reduces brain cell death in mice could mark a new target for treatments against Alzheimer’s disease.
-
Rothman, Schekman and Südhof - 2013 Nobel Prize winners in Physiology or Medicine
7th October 2013
The Nobel Prize in Physiology or Medicine 2013 was awarded jointly to James E. Rothman, Randy W.
-
Rejection reduced by animal research
4th October 2013
Consultant surgeon Geoff Koffman explains that while the prognosis for kidney transplant has improved rejection is still a problem.
Follow us: